Dupixent (dupilumab), first treatment for chronic rhinosinusitis with nasal polyps
16 Luglio 2019
The U.S. Food and Drug Administration has approved Dupixent (dupilumab) to treat adults with nasal polyps (growths on the inner lining of the sinuses) accompanied
